KENS 5: FDA approves new breast cancer treatments, offering hope for early and late-stage patients
May 27, 2026
KENS 5: FDA approves new breast cancer treatments, offering hope for early and late-stage patients
KABB TV (Fox SA): Focus on South Texas
May 24, 2026
Colton Jones, MD, hematology and oncology fellow at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), was interviewed for this news segment. Watch Now
Becker’s Health IT: 20 most trusted health system brands
May 22, 2026
Becker’s Health IT: 20 most trusted health system brands
Texas Public Radio: A new name and a big investment for the UT San Antonio School of Public Health
May 22, 2026
Texas Public Radio: A new name and a big investment for the UT San Antonio School of Public Health
KENS 5: UTSA graduates from health programs walk the stage
May 22, 2026
KENS 5: UTSA graduates from health programs walk the stage
San Antonio Report: Health Confianza starts new preventive health ‘one-stop shop’ for Bexar County residents
May 22, 2026
San Antonio Report: Health Confianza starts new preventive health ‘one-stop shop’ for Bexar County residents
Healthcare Design: UT Health San Antonio Brings Advanced Cancer Care Closer To South Texas
May 22, 2026
Healthcare Design: UT Health San Antonio Brings Advanced Cancer Care Closer To South Texas
Becker’s ASC Review: UT Health San Antonio pairs AI with colonoscopy detection
May 21, 2026
Becker’s ASC Review: UT Health San Antonio pairs AI with colonoscopy detection
$470 million investments by UT System accelerate UT San Antonio’s rise as a world-class research university
May 21, 2026
The University of Texas System Board of Regents has authorized approximately $470 million in capital investments supporting UT San Antonio’s continued growth as one of the nation’s fastest-rising public research universities and academic health institutions.
Study reveals hidden role of brain fats in Alzheimer’s disease
May 21, 2026
For decades, Alzheimer’s disease research has focused almost exclusively on harmful proteins in the brain. But scientists at The University of Texas at San Antonio are taking a new approach to how the disease is understood and treated.